BD Life Sciences–Biosciences, a division of global medical technology company BD, has inaugurated its first Centre of Excellence (CoE) for Single-cell multiomics in India. This significant collaboration with the CSIR-Institute of Genomics and Integrative Biology (IGIB) aims to accelerate breakthrough research across the country. Furthermore, this CoE will serve as a crucial hub for training, application support, and collaborative research.
Advancing Single-cell multiomics Research in India
The new CoE integrates BD’s cutting-edge Rhapsody Single Cell Analysis Solutions with IGIB’s established capabilities. Specifically, these capabilities include high-throughput next-generation sequencing (NGS) and advanced bioinformatics. This synergy enables researchers to generate deeper insights into complex cellular behavior, ultimately driving discoveries in fields like immunity, cancer, and precision medicine. Consequently, the centre will help translate intricate biological data into practical, real-world healthcare solutions, aligning with BD’s mission of advancing global health.
CSIR-IGIB Director, Dr. Souvik Maiti, noted that the partnership will significantly strengthen India’s research capabilities. Moreover, he emphasised that collaborating with BD creates a platform that actively fosters innovation. This, therefore, supports national priorities in genomics, molecular medicine, and bioinformatics. The initiative is a major step toward building a robust ecosystem for advanced research and capacity building among clinicians and researchers nationwide.
Key Technologies and National Impact
The BD Rhapsody platform offers a comprehensive solution for single-cell analysis. It allows for high-throughput sequencing of both RNA and protein from individual cells. This capability is vital for understanding the complex cellular heterogeneity inherent in diseases such as cancer and autoimmune disorders. In addition, the partnership leverages CSIR-IGIB’s expertise as a leading Indian institution focusing on translational research, thereby helping address national health challenges. BD Biosciences has also established other Centres of Excellence in India, including the BD-NCBS CoE in Advanced Flow Cytometry in Bengaluru and the BD-CMC Vellore CoE in Clinical Flow Cytometry, showcasing a commitment to fostering technological advancement across the country.
For professionals looking to deepen their understanding of the molecular basis of disease progression, especially in areas like oncology, courses focusing on Clinical Oncology or broader Genomic Medicine provide valuable structured education.
Frequently Asked Questions
Q1: What is the primary purpose of the BD-CSIR-IGIB Centre of Excellence?
The primary purpose is to advance single-cell multiomics research in India by serving as a collaborative hub for training, application support, and research, with a focus on areas like immunity, cancer, and precision medicine.
Q2: Which technologies are being integrated at the new CoE?
The Centre of Excellence integrates BD’s Rhapsody Single Cell Analysis Solutions with CSIR-IGIB’s capabilities in high-throughput next-generation sequencing (NGS) and bioinformatics.
References
- BD Biosciences, CSIR-IGIB launch Centre of Excellence for single-cell multiomics – ETHealthworld
- Single-cell multiomics: A comprehensive approach to cellular analysis.
- The role of BD Rhapsody in advancing high-throughput single-cell sequencing.
- CSIR-IGIB’s contributions to genomics and molecular medicine in India.
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.